Skip to main content


We are in the process of rolling out a soft launch of the RDA website, which includes a new member platform. Existing RDA members PLEASE REACTIVATE YOUR ACCOUNT using this link: Visitors may encounter functionality issues with group pages, navigation, missing content, broken links, etc. As you explore the new site, please provide your feedback using the UserSnap tool on the bottom right corner of each page. Thank you for your understanding and support as we work through all issues as quickly as possible. Stay updated about upcoming features and functionalities:


HI Mark,
My colleagues in the Photon and Neutron facilities (PaNSIG IG) are planning to submit a session proposal on “Sharing FAIR Data on COVID research at Photon and Neutron Facilities”.
I was in touch with Rob Hooft and we may join up with the ELIXIR Bridging force IG.
– Show quoted text -From: ***@***.*** on behalf of mleggott via RDA COVID19 Coordination
Sent: 22 January 2021 18:58
To: RDA COVID-19 Co-Chairs and Moderators
Subject: [rdacovid19-coordination] RDA P17 submissions
Hi all, I know I am leaving this a little late in the process, but wanted to check with you all to see if anyone has, or is considering, submitting COVID-19 specific session proposals for P17?
I was planning to accommodate the COVID-19 WG itself in the context of the emerging Infectious disease Community of Practice, which will be submitted for RDA/broader community review shortly. I am also hoping that there will be a submission for the first meeting of the ID CoP, even though the CoP review process is still underway.
As a reminder, the deadline is this coming Tuesday, so please let me know via Reply in this thread if you are part if submissions, thanks!
Mark Leggott, Executive Director / Directeur exécutif
Research Data Canada / Données de recherche Canada
Co-Chair, Research Data Alliance (RDA) Council
Chair, CODATA International Data Policy Committee
Secretary, Canadian National Committee for CODATA (CNC CODATA)
45 O’Connor Street, Suite 1150 Ottawa, ON K1P 1A4 Canada
w – t – 613.220.7236 f – 613.943.5443 e – ***@***.***
Skype – markleggott Twitter – @rdc_drc LinkedIn –
Book a Meeting with Me –
This email and any attachments are intended solely for the use of the named recipients. If you are not the intended recipient you must not use, disclose, copy or distribute this email or any of its attachments and should notify the sender immediately and delete this email from your system. UK Research and Innovation (UKRI) has taken every reasonable precaution to minimise risk of this email or any attachments containing viruses or malware but the recipient should carry out its own virus and malware checks before opening the attachments. UKRI does not accept any liability for any losses or damages which the recipient may sustain due to presence of any viruses. Opinions, conclusions or other information in this message and attachments that are not related directly to UKRI business are solely those of the author and do not represent the views of UKRI.